Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormone Replacement in Menopausal Women With Epilepsy
NCT00027209Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of medroxyprogesterone acetate in menopause, sponsored by National Institute of Neurological Disorders and Stroke. Status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
menopause
Beyond the preview
Go deeper on NCT00027209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00027209.